Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elihu Estey

Showing results (51-60 of 158) with videos related to

Pageof 16
Sort By:
Leukemia & Lymphoma|February 10, 2010
Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patientsSara S Strom, Elihu Estey, Ubaldo Martinez Outschoorn, et al.
Cancer|April 25, 2003
Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experienceGuillermo Lazo, Hagop Kantarjian, Elihu Estey, et al.
Leukemia & Lymphoma|January 7, 2006
Prognostic significance of monocytosis in patients with myeloproliferative disordersMiloslav Beran, Yu Shen, Francesco Onida, et al.
Leukemia|January 10, 2020
Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse?Elihu Estey, Judith E Karp, Ashkan Emadi, et al.
Haematologica|April 2, 2008
Relapse and death during first remission in acute myeloid leukemiaMasamitsu Yanada, Guillermo Garcia-Manero, Gautam Borthakur, et al.
Haematologica|October 9, 2002
Ursodiol does not prevent hepatic venoocclusive disease associated with Mylotarg therapyFrancis Giles, Guillermo Garcia-Manero, Jorge Cortes, et al.
Leukemia Research|July 16, 2003
Pilot study of gemtuzumab ozogamicin, liposomal daunorubicin, cytarabine and cyclosporine regimen in patients with refractory acute myelogenous leukemiaEfrosyni Apostolidou, Jorge Cortes, Apostolia Tsimberidou, et al.
Haematologica|June 4, 2008
Kinetics of bone marrow blasts during induction and achievement of complete remission in acute myeloid leukemiaMasamitsu Yanada, Gautam Borthakur, Farhad Ravandi, et al.
Cancer|October 24, 2007
Potential cure of acute myeloid leukemia : analysis of 1069 consecutive patients in first complete remissionMasamitsu Yanada, Guillermo Garcia-Manero, Gautam Borthakur, et al.
Statistics in Medicine|March 28, 2009
Using short-term response information to facilitate adaptive randomization for survival clinical trialsXuelin Huang, Jing Ning, Yisheng Li, et al.
Pageof 16

Showing results (51-60 of 158) with videos related to

Sort By:
Pageof 16
Leukemia & Lymphoma|February 10, 2010
Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patientsSara S Strom, Elihu Estey, Ubaldo Martinez Outschoorn, et al.
Cancer|April 25, 2003
Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experienceGuillermo Lazo, Hagop Kantarjian, Elihu Estey, et al.
Leukemia & Lymphoma|January 7, 2006
Prognostic significance of monocytosis in patients with myeloproliferative disordersMiloslav Beran, Yu Shen, Francesco Onida, et al.
Leukemia|January 10, 2020
Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse?Elihu Estey, Judith E Karp, Ashkan Emadi, et al.
Haematologica|April 2, 2008
Relapse and death during first remission in acute myeloid leukemiaMasamitsu Yanada, Guillermo Garcia-Manero, Gautam Borthakur, et al.
Haematologica|October 9, 2002
Ursodiol does not prevent hepatic venoocclusive disease associated with Mylotarg therapyFrancis Giles, Guillermo Garcia-Manero, Jorge Cortes, et al.
Leukemia Research|July 16, 2003
Pilot study of gemtuzumab ozogamicin, liposomal daunorubicin, cytarabine and cyclosporine regimen in patients with refractory acute myelogenous leukemiaEfrosyni Apostolidou, Jorge Cortes, Apostolia Tsimberidou, et al.
Haematologica|June 4, 2008
Kinetics of bone marrow blasts during induction and achievement of complete remission in acute myeloid leukemiaMasamitsu Yanada, Gautam Borthakur, Farhad Ravandi, et al.
Cancer|October 24, 2007
Potential cure of acute myeloid leukemia : analysis of 1069 consecutive patients in first complete remissionMasamitsu Yanada, Guillermo Garcia-Manero, Gautam Borthakur, et al.
Statistics in Medicine|March 28, 2009
Using short-term response information to facilitate adaptive randomization for survival clinical trialsXuelin Huang, Jing Ning, Yisheng Li, et al.
Pageof 16